title: Potential role of glycerol leading to rat fructose hypertension.
abstract: A fructose-enriched diet promotes hypertension in rats. We thought that an enhancement of the glycolytic and/or lipid disorder (s) that raise blood pressure could be the cause. Therefore, we studied 4 groups of Sprague-Dawley rats (+/-200 g): (1) control rats received a standard diet and tap water; (2) the glycerol group of rats received a standard diet and 0.54 mol/L glycerol in tap water; (3) the fructose group was given a fructose-enhanced diet (chow had 55% fructose instead of dextrin) and tap water; and (4) the fructose-glycerol group was given the fructose-enhanced diet and 0. 54 mol/L glycerol in drinking water. At the end of the second week, the findings were as follows. Blood pressure was 149+/-2 mm Hg in the fructose-glycerol group versus 129+/-2 (P<0.001), 131+/-2 (P<0. 001), and 140+/-3 (P<0.005) mm Hg in the control, glycerol, and fructose groups, respectively. Insulinemia was higher in the fructose-glycerol group than the control (P<0.001), glycerol (P<0. 001), and fructose groups (P<0.001); triglyceridemia was higher in the fructose-glycerol (P<0.02), fructose (P<0.05), and glycerol groups (P<0.02) than the control group. Thoracic aorta rings showed a lower ED(50) to 12,13-phorbol dibutyrate in the fructose-glycerol group than in the control (P<0.001), glycerol (P<0.002), and fructose groups (P<0.001). In conclusion, glycerol-fructose administration resulted in hypertriglyceridemia, hyperinsulinemia, and increased vascular sensitivity to 12,13-phorbol dibutyrate (with respect to the control group), and significantly greater expression of protein kinase C alpha and betaII (with respect to the glycerol group).
authors.affiliation: Department of Physiology, School of Medicine, Buenos Aires University, Argentina.
authors.forename: P F
authors.initials: PF
authors.lastname: Damiano
authors.forename: M I
authors.initials: MI
authors.lastname: Rosón
authors.forename: I
authors.initials: I
authors.lastname: Armando
authors.forename: S
authors.initials: S
authors.lastname: Nowicki
authors.forename: E
authors.initials: E
authors.lastname: Dascal
authors.forename: L
authors.initials: L
authors.lastname: Cuniberti
authors.forename: L E
authors.initials: LE
authors.lastname: Albornoz
authors.forename: I J
authors.initials: IJ
authors.lastname: de la Riva
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D004032:Diet; D004357:Drug Synergism; D005632:Fructose / Q000008:administration & dosage*; D005990:Glycerol / Q000494:pharmacology*; D006973:Hypertension / Q000139:chemically induced* / Q000378:metabolism / Q000503:physiopathology; D007328:Insulin / Q000378:metabolism; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D007328:Insulin; D005632:Fructose; D005990:Glycerol